Wilshire Bancorp Completes Acquisition of Saehan Bancorp

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Wilshire Bancorp Completes Acquisition of Saehan Bancorp

LOS ANGELES, Nov. 21, 2013 (GLOBE NEWSWIRE) -- Wilshire Bancorp, Inc. (Nasdaq: WIBC ) (the "Company"), the parent company of Wilshire Bank, today announced the completion of its acquisition of Saehan Bancorp effective as of November 20, 2013. Using September 30, 2013 financial information, following the consummation of the acquisitions of BankAsiana (which occurred on October 1, 2013) and Saehan Bancorp, Wilshire Bancorp has total assets of approximately $3.6 billion and total deposits of approximately $2.9 billion.

Effective November 20, 2013, all former Saehan Bank branches are operating under the Wilshire Bank name.

"We are pleased to complete our acquisition of Saehan Bancorp, which we believe will significantly expand our presence in the Los Angeles Metropolitan area and enhance the earnings power of our franchise," said J.W. Yoo, President and Chief Executive Officer of Wilshire Bancorp. "We are excited to welcome Saehan customers to Wilshire Bank and provide them with the exceptional level of personal service that has been the hallmark of Wilshire Bank over our 33-year history."

In the merger, Saehan shareholders received an aggregate of (1) 7,210,815 shares of Company common stock and (2) $50,369,522 in cash. Saehan shareholders had the right to elect to receive either (x) $0.4247 in cash, (y) 0.06080 shares of Wilshire common stock, or (z) a unit consisting of a mix of $0.21235 in cash and 0.03040 shares of Wilshire common stock, in exchange for each share of Saehan common stock, subject to proration, adjustment and certain limitations as set forth in the merger agreement.

ABOUT WILSHIRE BANCORP

Headquartered in Los Angeles, Wilshire Bancorp is the parent company of Wilshire Bank, which operates 38 branch offices in California, Texas, New Jersey and New York, and nine loan production offices in Dallas and Houston, TX, Atlanta, GA, Aurora, CO, Annandale, VA, Fort Lee, NJ, Newark, CA, New York, NY, and Bellevue, WA, and is an SBA preferred lender nationwide. Wilshire Bank is a community bank with a focus on commercial real estate lending and general commercial banking, with its primary market encompassing the multi-ethnic populations of the Los Angeles Metropolitan area. For more information, please go to www.wilshirebank.com .

ABOUT SAEHAN BANCORP

Saehan Bancorp is a bank holding company with headquarters in Los Angeles, California. Its wholly owned subsidiary, Saehan Bank, offers a comprehensive range of financial solutions to meet the needs of multi-ethnic communities in the United States. Saehan Bancorp is committed to satisfying customers and creating shareholder value. Its ten retail branch offices, International Department and SBA Department focus on fulfilling these commitments to customers and shareholders.

FORWARD-LOOKING STATEMENTS

Statements concerning future performance, events, or any other guidance on future periods constitute forward-looking statements that are subject to a number of risks and uncertainties that might cause actual results to differ materially from stated expectations. Such forward-looking statements include, but are not limited to, statements about the benefits of the proposed transaction involving Wilshire and Saehan including future financial and operating results, Wilshire's or Saehan's plans, objectives, expectations and intentions, the expected timing of completion of the transaction, and other statements that are not historical facts. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include risks and uncertainties relating to: (i) the risk that a condition to closing of the transaction may not be satisfied; (ii) the timing to consummate the proposed transaction; (iii) the risk that the businesses will not be integrated successfully; (iv) the risk that the cost savings and any other synergies from the transaction may not be fully realized or may take longer to realize than expected; (v) disruption from the transaction making it more difficult to maintain relationships with customers, employees or vendors; (vi) the diversion of management time on transaction-related issues; (vii) general worldwide economic conditions and related uncertainties; (viii) the effect of changes in governmental regulations; (ix) credit risk associated with an obligor's failure to meet the terms of any contract with the bank or to otherwise perform as agreed; (x) interest risk involving the effect of a change in interest rates on both the bank's earnings and the market value of the portfolio equity; (xi) liquidity risk affecting the bank's ability to meet its obligations when they come due; (xii) price risk focusing on changes in market factors that may affect the value of traded instruments in "mark-to-market" portfolios; (xiii) transaction risk arising from problems with service or product delivery; (xiv) compliance risk involving risk to earnings or capital resulting from violations of or nonconformance with laws, rules, regulations, prescribed practices, or ethical standards; (xv) strategic risk resulting from adverse business decisions or improper implementation of business decisions; (xvi) reputation risk that adversely affects earnings or capital arising from negative public opinion; (xvii) terrorist activities risk that results in loss of consumer confidence and economic disruptions; (xviii) economic downturn risk resulting in deterioration in the credit markets; (xix) greater than expected noninterest expenses; (xx) excessive loan losses; and (xxi) other factors Wilshire discusses or refers to in the "Risk Factors" section of its most recent Annual Report on Form 10-K filed with the SEC. Additional risks and uncertainties are identified and discussed in Wilshire's reports filed with the SEC and available at the SEC's website at www.sec.gov . Each forward-looking statement speaks only as of the date of the particular statement and Wilshire undertakes no obligation to update or revise its forward-looking statements, whether as a result of new information, future events or otherwise.

ADDITIONAL INFORMATION ABOUT THE MERGER WITH SAEHAN AND WHERE TO FIND IT

This communication relates or may be deemed to relate to the merger between Wilshire and Saehan Bancorp ("Saehan") that is the subject of a registration statement on Form S-4, including a proxy statement/prospectus, filed with the SEC on September 3, 2013 (No. 333-190971), as amended by Amendment No. 1 thereto, and declared effective by the SEC on October 1, 2013, that provides full details of the proposed merger and the attendant benefits and risks. The proxy statement/prospectus was filed with the SEC on October 2, 2013 and was mailed to Saehan shareholders on or about October 7, 2013. This communication is not a substitute for the proxy statement/prospectus or any other document that Wilshire or Saehan may file with the SEC or send to their shareholders in connection with the proposed merger . Investors and security holders are urged to read the registration statement on Form S-4, including the definitive proxy statement/prospectus, and all other relevant documents filed with the SEC or sent to shareholders as they become available because they will contain important information about the proposed merger. All documents, when filed, will be available free of charge at the SEC's website ( www.sec.gov ). You may also obtain these documents by contacting Wilshire's Corporate Secretary, at Wilshire Bancorp, Inc., 3200 Wilshire Boulevard, Los Angeles, California 90010, or via e-mail at alexko@wilshirebank.com. This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval.

Alex Ko, EVP & CFO, (213) 427-6560 www.wilshirebank.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Baidu Faces Class Action: Investors Push Against Fraud Allegations

Updated Category News Views 2

Baidu Under Fire for Alleged Misleading Statements Here's a fresh slice of drama straight outta the corporate trenches: Baidu, Inc. (NASDAQ: BIDU) finds itself tangled in a securities fraud lawsuit that’s causing a ruckus across investor circles. Schall, Brown & Schwartz LLP, those heavyweight gladiators in shareholder rights, are calling on grieved investors to step up...

Continue Reading
Food Trends Tease: 2027 sofi™ Awards' 75 Finalists

Updated Category News Views 1

The Specialty Food Scene Heats Up Today’s world doesn’t rest when it comes to innovation, and the same goes for the tantalizing realm of specialty foods. Hot off the press, the Specialty Food Association (SFA) just rolled out the red carpet for its 75 finalists in the 2027 sofi™ Awards. These are the future taste shapers set to take center stage at the Winter...

Continue Reading
Kenneth Smith Takes Helm for Trends Int’l Expansion

Updated Category News Views 0

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Continue Reading
LINC Lawsuit: Boardroom Stumbles Spark Investor Action

Updated Category News Views 4

Class Action Kickoff: Lincoln's Educational Curveball No one fancies home runs when the ball’s out of sight, and that’s probably how some investors in Lincoln Educational Services Corporation (NASDAQ: LINC) are feeling right now. A group of shareholders has pulled back the curtain on what they believe are more than just administrative hiccups—allegations of...

Continue Reading
Nest Health Appoints Peter Morrison for Multistate Expansion

Updated Category News Views 3

Peter Morrison Steps Up as Chief Growth Officer You know, it's not every day you see a move as gutsy as Nest Health's recent appointment of Peter Morrison. They're shaking up the Medicaid space, aiming to redefine primary care for families with limited resources. Morrison, coming from heavyweights like UnitedHealthcare and Centene, isn't your typical pencil-pusher. He’s...

Continue Reading
Senté’s Heparan Sulfate Pairing: Peer-Reviewed Success

Updated Category News Views 0

Senté's Science-Driven Approach in Skincare Alright, cutting through the skincare noise, Senté Labs has pulled off something impressive—not just another jar of promises but actual, peer-reviewed science backing their Defense C Serum. Published in the Journal of Cosmetic Dermatology, this study isn't just talk about ingredients; it's a show of real results. This isn't...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 11

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
QFIN Faces Class Action: Investors' Role Explored

Updated Category News Views 0

Cracks in the Facade: QFIN's Legal Mess You're cruising down the usual market lanes when—bam!—news breaks that Qfin Holdings, Inc. (NASDAQ: QFIN) finds itself hip-deep in a class action lawsuit. Seems like our pals at Schall, Brown & Schwartz LLP have thrown the gauntlet down, with claims of some serious smoke and mirrors during the March to August stretch of 2026....

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 6

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
De¹ Unveils Tokenization Model on BNB Chain

Updated Category News Views 2

De¹'s Bold Move into Enhanced Digital Finance Just when you thought the financial landscape couldn’t get any more complex, De¹ steps into the ring with its Tokenized Asset World on the BNB Chain—a move that's stirring the pot of tokenized finance in more ways than one. For old-school investors who thrive on waving outlandish stock bets, this crypto narrative is a...

Continue Reading

Top 5 Most Recently Viewed Articles

NOV Inc. Announces Scheduled Cash Dividend for Shareholders

Updated Category News Views 124

NOV Inc. Announces Scheduled Cash Dividend for Shareholders HOUSTON — NOV Inc. (NYSE: NOV) is excited to share that the Board of Directors has recently made the decision to declare a quarterly cash dividend amounting to $0.075 per share. This dividend is set to be paid on December 19 to all stockholders who are on record as of December 5. The Role of NOV in the Energy...

Continue Reading
Enlivex Therapeutics Shares Promising Results for Osteoarthritis

Updated Category News Views 89

Enlivex Therapeutics Reports Positive Efficacy Data from Allocetra Trial Nes-Ziona, Israel – Enlivex Therapeutics Ltd. (NASDAQ: ENLV) has announced encouraging interim results from its Phase I/II Allocetra™ trial focusing on patients with moderate to severe knee osteoarthritis. This randomized multi-country study marks a significant step forward in the company’s...

Continue Reading
Wing Yip Food Holdings Complete First Public Offering Success

Updated Category News Views 108

Wing Yip Food Holdings Completes Successful IPO Wing Yip Food Holdings Group Limited (Nasdaq: WYHG) has successfully concluded its initial public offering (IPO), marking a significant milestone for the company. This meat processing company, operating subsidiaries in mainland China, raised approximately US$8.20 million through the offering of 2,050,000 American Depositary...

Continue Reading
Alkami Technology's Growth: Price Target Raised to $40

Updated Category News Views 30

Alkami Technology's Stock Outlook Enhanced Alkami Technology Inc (NASDAQ: ALKT) has recently captured the attention of investors and analysts alike with its impressive growth trajectory. According to recent reports, the price target for Alkami’s shares has been raised from $35 to $40 by Stephens, indicating a strong belief in the company’s continued success while...

Continue Reading
Confidein Secures $6 Million Seed Funding for Prayer Tech Expansion

Updated Category News Views 283

Confidein's Innovative Prayer Ring Initiative In an inspiring move, Confidein, a dedicated technology company at the intersection of faith and innovation, has successfully concluded a $6 million seed funding round. This funding, driven by influential Christian leaders and leading venture capitalists, sets the stage for a transformative campaign to benefit Christian...

Continue Reading